Accueil・Liste d'Actions・Cytek Biosciences Inc

Cytek Biosciences Inc

Fermé

SecteurSoins de santé

4.22 1.44

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

4.09

Max

4.22

Chiffres clés
By Trading Economics
Revenu	25M -19M
Ventes	-18M 44M
BPA	-0.1
Marge bénéficiaire	-42.746
Employés	678
EBITDA	-14M -14M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+33.65% upside

Dividendes
By Acuity
Prochains Résultats	4 nov. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-45M 557M
Ouverture précédente	2.78
Clôture précédente	4.22

Sentiment de l'Actualité

By Acuity

50%

151 / 340 Classement par Healthcare

Cytek Biosciences Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 août 2026, 19:36 UTC

Cytek Biosciences Inc is higher today, supported by broader market gains amid expectations of a Federal Reserve pause on interest rate hikes.

6 août 2026, 20:02 UTC

News

Cytek Biosciences raises 2026 revenue guidance to $207 million-$212 million, aligning with consensus. Shares are higher despite a mixed earnings report.

5 août 2026, 22:02 UTC

News

Cytek Biosciences shares are lower in after-market hours following a second-quarter earnings miss and revenue that fell short of expectations.

4 août 2026, 20:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting broader market trends after a notable early peak. Overall market performance has declined since Monday.

3 août 2026, 19:56 UTC

Cytek Biosciences Inc. shares are higher today, reflecting broader market trends as major indices gain amid easing geopolitical tensions. No specific news was identified.

31 juil. 2026, 19:26 UTC

Correlated Moves

Cytek Biosciences Inc shares are lower as first-quarter results show a significant decline, reflecting broader sector pressures amid rising bond yields.

30 juil. 2026, 19:18 UTC

Cytek Biosciences Inc. shares are lower today, reflecting ongoing weakness and trading significantly below the 20-day moving average amid broader market volatility.

27 juil. 2026, 19:56 UTC

Cytek Biosciences Inc is trading lower today, retracing from an early peak. The asset remains near the lower end of its one-month trading range.

24 juil. 2026, 17:16 UTC

Cytek Biosciences Inc. shares are lower today, declining after an early peak. The asset remains below its 20-day moving average amid broader market volatility.

23 juil. 2026, 19:46 UTC

Cytek Biosciences Inc. shares are trading roughly flat, reflecting limited movement since Wednesday. Earlier, shares peaked before retracing to current levels.

21 juil. 2026, 19:06 UTC

Cytek Biosciences Inc shares are lower today, continuing a three-session decline amid broader market conditions. No specific news was identified to explain the movement.

20 juil. 2026, 19:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting routine fluctuations near the upper end of their one-month trading range amid a broader market decline.

Comparaison

Variation de prix

Cytek Biosciences Inc prévision

Objectif de Prix

By TipRanks

33.65% hausse

Prévisions sur 12 Mois

Moyen 5.56 USD 33.65%

Haut 7.5 USD

Bas 4.75 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

4 ratings

Achat

Maintien

Vente

Basé sur 4 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

151 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.